Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.

Internationality Nuclear Medicine / statistics & numerical data Positron-Emission Tomography Radiopharmaceuticals / supply & distribution Tomography, Emission-Computed, Single-Photon
access global issues radiopharmaceuticals

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
03 2021
Historique:
received: 11 04 2020
accepted: 15 06 2020
pubmed: 11 7 2020
medline: 5 3 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

The Nuclear Medicine Global Initiative was formed in 2012 by 13 international organizations to promote human health by advancing the field of nuclear medicine and molecular imaging by supporting the practice and application of nuclear medicine. The first project focused on standardization of administered activities in pediatric nuclear medicine and resulted in 2 articles. For its second project the Nuclear Medicine Global Initiative chose to explore issues impacting on access and availability of radiopharmaceuticals around the world.

Identifiants

DOI: 10.2967/jnumed.120.247197 PMID: 32646881 PMC: PMC8049350
pubmed: 32646881
pii: jnumed.120.247197
doi: 10.2967/jnumed.120.247197
pmc: PMC8049350
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-430

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Nucl Med. 2015 Apr;56(4):646-51
pubmed: 25766899
Indian J Nucl Med. 2013 Oct;28(4):195-9
pubmed: 24379527
J Nucl Med. 1971 Jan;12(1):22-4
pubmed: 5539900
J Nucl Med. 2020 May;61(5):626-629
pubmed: 32238430
J Nucl Med. 2011 Dec;52 Suppl 2:16S-23S
pubmed: 22144549
Contrast Media Mol Imaging. 2018 Jun 5;2018:1382183
pubmed: 29967571
Semin Nucl Med. 2019 Sep;49(5):450-457
pubmed: 31470937
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1615-1619
pubmed: 32296886
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1645-1648
pubmed: 32232520
J Nucl Med. 1970 Dec;11(12):761
pubmed: 5490410
J Nucl Med. 2016 Jul;57(7):1148-57
pubmed: 27033894

Auteurs

Cathy S Cutler (CS)

Brookhaven National Laboratory, Upton, New York.

Elizabeth Bailey (E)

Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Vijay Kumar (V)

Department of Nuclear Medicine and PET, Westmead Hospital and Children's Hospital at Westmead, and University of Sydney, New South Wales, Australia.

Sally W Schwarz (SW)

Washington University School of Medicine, St Louis, Missouri.

Hee-Seung Bom (HS)

Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeollanam, Korea.

Jun Hatazawa (J)

Department of Quantum Cancer Therapy, Research Center for Nuclear Physics, Osaka University, Osaka, Japan.

Diana Paez (D)

Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria.

Pilar Orellana (P)

Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria.

Lizette Louw (L)

Department of Nuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital and University of Witwatersrand, Johannesburg, South Africa.

Fernando Mut (F)

Nuclear Medicine Service, Italian Hospital, Montevideo, Uruguay.

Hiroki Kato (H)

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan.

Arturo Chiti (A)

Department of Biomedical Sciences, Humanitas University, and Nuclear Medicine Unit, Humanitas Research Hospital-IRCCS, Milan, Italy.

Savvas Frangos (S)

Department of Nuclear Medicine, Bank of Cyprus Oncology Center, Nicosia, Cyprus.

Frederic Fahey (F)

Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Gary Dillehay (G)

Department of Radiology, Division of Nuclear Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Seung J Oh (SJ)

Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Dong S Lee (DS)

Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.

Sze-Ting Lee (ST)

Department of Molecular Imaging and Therapy, Austin Health; University of Melbourne; Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Australia.

Rodolfo Nunez-Miller (R)

Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria.
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.

Guru Bandhopadhyaya (G)

Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India; and.

Prasanta K Pradhan (PK)

Department of Nuclear Medicine, Sanjay Gandhi Post Graduate Institute of Nuclear Medicine, Lucknow, India.

Andrew M Scott (AM)

Department of Molecular Imaging and Therapy, Austin Health; University of Melbourne; Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Australia andrew.scott@austin.org.au.

Articles similaires

99mTc-GSA scintigraphy and modified albumin-bilirubin score can be complementary to ICG for predicting posthepatectomy liver failure.

Satoshi Mii, Takeshi Takahara, Susumu Shibasaki et al.
1.00
Humans Hepatectomy Male Female Retrospective Studies

Anhui Zhu, Xiaoyan Hou, Na Guo et al.
1.00
Humans Carcinoma, Renal Cell Vena Cava, Inferior Male Female

Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation.

Mahsa Shanaki Bavarsad, Salvatore Spina, Abby Oehler et al.
1.00
Humans Synaptophysin Aged Female Positron-Emission Tomography

Non-invasive assessment of programmed cell death ligand-1 expression using

Liming Miao, Gang Xiao, Wanqi Chen et al.
1.00
Humans B7-H1 Antigen Positron Emission Tomography Computed Tomography Esophageal Squamous Cell Carcinoma Fluorodeoxyglucose F18

Classifications MeSH

questionsmedicales.fr › Sciences sociales › Internationalité › Global Issues of Radiopharmaceutical Access...
questionsmedicales.fr › Professions de santé › Médecine › Radiologie › Médecine nucléaire › Global Issues of Radiopharmaceutical Access...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Global Issues of Radiopharmaceutical Access...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Global Issues of Radiopharmaceutical Access...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission monophotonique › Global Issues of Radiopharmaceutical Access...